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CHAPTER 1 Analogs of Tamiflu Introduction
Tamiflu is a very selective and potent inhibitor of influenza neuraminidase at nanomolar concentrations and as a result was launched as a drug in 1999. 1 It is used as an oral treatment for the prevention of influenza virus infections, such as bird flu. Tamiflu is effective against both influenza A and B viruses and was discovered by Gilead Sciences 2 ' 3 in 1995 and developed by Hoffmann-LaRoche. 4 The prodrug is commercially available as a capsule that contains 75 milligrams of oseltamivir for oral use and as a powder for oral suspension, which, when it is constituted with water in the required amount, contains 12 mg/mL of oseltamivir base. The first antiviral treatments for influenza were amantadine and rimantadine, which are inhibitors of the M2 ion channel protein contained within the influenza virus. Both agents have been shown to be effective, but they are only active against influenza virus A, because influenza virus B does not possess an M2 protein. 6 Another disadvantage of this treatment system is that adamantine-resistant influenza A viruses emerge readily due to mutations after use of both agents. 7 In contrast, the mutations required to give resistance to the neuraminidase inhibitors are at the highly conserved active site of the neuraminidase enzyme.
This therefore allows the neuraminidase inhibitors to be active against all influenza A and B subtypes.
Synthesis of Tamiflu
The two starting materials used in the synthesis of Tamiflu are shikimic acid and quinic acid. Shikimic acid is obtained by extraction of the Chinese star anise or from fermentation where a genetically engineered E. coli strain is used. 1 Quinic acid is one of the by-products that is obtained from the extraction of quinine for tonic water from the bark of the African cinchona tree. 1 Shikimic acid is preferred as a starting material over quinic acid, because it already has the carbon-carbon double bond functionality that is required in the target molecule.
In the technical synthesis of Tamiflu The first synthesis of Tamiflu involved formation of a diketal intermediate 2, which was first obtained from quinic acid in 5 steps and later from shikimic acid in 4 steps. The diketal was then opened regioselectively to introduce the pentyl ether functionality, which was followed by epoxidation to give a key intermediate in the synthesis of Tamiflu. The amino groups were then introduced by azide chemistry, which involved the formation of aziridines.
Other strategies for introduction of the two amino groups present in Tamiflu that were azidefree were later developed. The first type of azide-free chemistry involved the use of an allyl amine. 8 In the second generation of the azide-free synthesis of Tamiflu, a tert-butylamine group was introduced. This led to an increased yield (61 %) for the synthesis of Tamiflu from the epoxide precursor 3 ( Figure 2 ). 9 Two different syntheses of Tamiflu have been reported in the literature recently by Corey et al 10 and Shibasaki etal n The key steps in the Corey synthesis are shown in Figure   3 . The first step, a Diels Alder reaction, uses butadiene and trifluoroethyl aery late. 
Figure 3. Corey Synthesis
It is followed by modification of the ester to give amide 4. lodol actamizati on of 4, protection and then dehydroiodination gave compound 5. Allylic bromination of 5 and treatment with CsCO] gave diene ethyl ester 6. Conversion of 6 to diamide 7 involves a novel SnBr 4 catalyzed bromoacetamidation using 7V-bromoacetamide (NBA) that is regioselective and stereoselective. Compound 7 was cyclized to an 7V-acetylaziridine and regioselectively opened with 3-pentanol. Removal of the protecting group and salt formation with H3PO4 gave Tamiflu in 11 steps. The last four steps have not been optimized, meaning that no overall yield was reported.
The Shibasaki synthesis also uses aziridine chemistry, where the first key step is a catalytic enantioselective ring opening of aziridine 8 using TMSN3 to give compound 9 ( Figure 4 ). The symmetrical diamide 10 was then synthesized from 9 in 4 steps. Allylic oxidation and 1,4-addition of TMSCN gave ketonitrile 11. The keto group was selectively reduced to an alcohol after which the pentyl ether was introduced. Boc deprotection using TFA, then protection of the less sterically hindered amine was followed by acetylation. Conversion of the nitrile to the ester was associated with removal of the protecting group. Salt formation gave Tamiflu, 1, in 7 steps from 11. The Shibasaki synthesis took 21 steps with a 50 % yield of 1 from the penultimate step.
Methodology
Our strategy was to make analogs of Tamiflu in as few steps as possible. Crotonaldehyde, an a,P-unsaturated aldehyde, was used to determine the optimal reaction conditions under which the annulation would occur with phosphonate 13. Initially, the goal was to make the dianion using two equivalents of bases, such as fBuOK or NaOMe, so that the Wittig reaction would occur first as shown in Figure 5 . HO. 15 16 These reaction intermediates support the mechanism in Figure 6 , which is proposed for the
,©f
0O" Initially, most of the reactions were carried out from 0 °C to 25 °C. To push the reaction further to completion, the reaction mixture was heated under reflux conditions. The desired product was successfully obtained using DBU under the conditions shown for the main reaction in Table 1 .
The next step was to see what other (^-unsaturated aldehydes or ketones would react with phosphonate 13. Most of the (^-unsaturated aldehydes or ketones used were commercially available, but some were synthesized in 2 to 3 steps. Several analogs of Tamiflu were synthesized successfully using the [3+3] annulation as shown in Table 1 . All the products in Table 1 , except for analog 12b, were predominantly one diastereomer. Proton NMR data supports a trans-diequatorial relationship between the nitro group and R 2 . The trans isomer was the major product isolated for analogs 12a and 12c and was the only isomer isolated for 12d and 12e. In the case of the bicyclic products, 12g and 12h, the nitro group appears to be on the exo face of the fused bicyclic ring system. In the nitro analog 12g, the ratio of exo to endo nitro group was 9:1 and in analog 12h the ratio of exo to endo for the nitro group was 4:1. Table 2 shows other aldehydes and ketones that were also reacted with phosphonate 13, but the reactions did not occur successfully. 
The next step was to make sure that the nitro group could be successfully reduced to an amino group. The selective reduction of an aliphatic nitro group in the presence of an unsaturated ester has relatively little literature precedent. 14 The methyl, cyclopentyl and phenyl groups were chosen as these would represent the three different types of analogs which either had an aliphatic, cyclic or aromatic substituent. The reduction was successfully carried out using tin and concentrated hydrochloric acid in ethanol. 15 The amino analogs 17, 18 and 19 were obtained from nitro analogs 12a, 12g, and 12c in 67 %, 86 % and 72 % yields, respectively. 
Alternate Route
The above route for making the analogs has the disadvantage that cis/trans isomers may be formed. The diastereomers may be separated for the most part by chromatography.
However, some of the diastereomers have the same Rf value. This leads to a decrease in the amount of the desired isomer being obtained. The next thing to do was to plan another model system for the synthesis of Tamiflu. This new route involved the synthesis of an isoxazoline.
The first isoxazoline was made from methyl 4-nitrobutyrate, ethyl crotonate and phenyl isocyanate in the presence of triethylamine. The reaction involves formation of a nitrile oxide that is involved in a cycloaddition with a dipolarophile. 16, 17 The cycloaddition is also concerted. It was later discovered that regioisomers are formed using this method and the major isomer is the undesired regioisomer.
NO2 + PhNCO
/=o
The next step was to look for a route where the isoxazoline could be made regioselectively via a nitrile oxide. Isoxazolines can be made regioselectively by using nitro alkanes, dipolarophiles and a catalytic amount of DMAP. 18 The same reaction conditions were applied to methyl 4-nitrobutyrate and ethyl aery late, but the desired product was not obtained. The methyl 4-nitrobutyrate did not react and was the main compound present by proton NMR spectroscopy. Modifications to the reaction, which included changing the solvent, resulted in the desired product. The yield was further increased to 76% by using Shimizu's method. 19 That was achieved by using methyl 4-nitrobutyrate, ethyl acrylate, ethyl chloroformate, and triethylamine using chloroform as the solvent. 19 Due to the nature of the dipolarophile a mixture of diastereomers is obtained.
The mechanism for formation of the nitrile oxide and the cycloaddition is shown below.
-EtOCOOH
Once the isoxazoline was made, the next step was to cyclize the isoxazoline that contained two ester groups to a six-membered ring. Several attempts were made to alkylate the imine in the ring using reagents such as dimethyl sulfate 20 and tri ethyl oxonium tetrafluoroborate. 21 The methylation was achieved successfully with methyl triflate.
After this, the iminium salt was reduced to an amine. Reduction using NaBH 4 resulted in the loss of one of the ester groups. The desired reduction was achieved with NaBH 3 CN under acidic conditions where a mixture of diastereomers was obtained. The main disadvantage of this reaction is that it resulted in a low yield.
Once the amine was formed, the cyclization to the six-membered ring was attempted under basic conditions using NaOMe/MeOH, or zBuOK/zBuOH. None of the conditions used resulted in successful cyclization of the amine. The use of base facilitates epimerization, which would later lead to cyclization to obtain the desired product. The main advantage of successful cyclization is that the compound formed has the desired stereochemistry of Tamiflu.
Summary
This work has shown the synthesis of eight nitro analogs of Tamiflu in yields from 24 % to 74 % and three amino analogs in yields from 67 % to 86 %. The most attractive feature of this synthesis is that it only involves 2 steps. The reaction seems to work best with a,Punsaturated aldehydes or ketones that contain trans carbon-carbon double bonds. In addition the analogs have the ester, amino and carbon-carbon double bond functionalities, which are key components in Tamiflu.
An alternate route for the synthesis of Tamiflu provides a model system from which the desired product may be synthesized. An isoxazoline, which is a key intermediate for this 
General Procedure for analogs
To a solution of (^-unsaturated aldehyde or ketone (0.34 mmol) in CH2CI2 was added DBU (0.64 mmol). The reaction mixture was cooled to 0 °C. After 10 min, a solution of 13 (0.34 mmol) in CH2CI2 was added drop wise to the reaction mixture and allowed to warm to rt. over 2 h. The reaction mixture was then heated at 50 °C for another 2 h. 2N HCl was added to the reaction mixture after cooling to rt. The organic layer was washed one more time with 2N
HCl and once with brine, dried (Mg 2 S04) and evaporated to give an orange oil. Column chromatography on silica gel yielded the product. 
4-Methyl-5-nitro-l-cyclohexenecarboxylic acid, ethyl ester (12a
2-Methyl-4-phenyl-5-nitro-l-cyclohexenecarboxylic acid, ethyl ester (12d
General Procedure for Reduction of the Nitro Analogs
To a solution of the nitro analog (1 equiv.) in EtOH was added Sn (5 .3 equiv). The reaction was heated to 70 °C and 12 M HCl (54 equiv.) was added. The reaction mixture was refluxed for 20 min and cooled to rt. The solution was made weakly basic with 2M NaOH and extracted with EtOAc. The combined organic layers were washed once with brine, dried (Mg 2 SÛ4) and evaporated to give a yellow oil. Flash column chromatography on silica gel yielded the product. 
4-Methyl-5-amino-l-cyclohexenecarboxylic acid, ethyl ester (17
Extraction of Prunella Vulgaris
Introduction
Dietary botanical supplements are used by about 7% of the American population as presumed preventatives and for the treatment of diverse diseases, such as depression and viral infections. 1 Despite the extensive use of these supplements, scientific studies to understand the biological properties of the compounds present in these plant extracts are limited and the efficacy of many of the supplements is unclear. The Iowa Botanical Supplement Research Center has been conducting anti-viral and anti-inflammatory studies on the Prunella species, which exhibits both types of activities.
Background
There are a few drugs that have emerged for HIV treatment and include nucleoside and non-nucleoside reverse-transcriptase inhibitors and protease inhibitors. 2 One example of this class of drugs is AZT (zidovudine), which is a nucleoside inhibitor and prevents HIV replication. The main drawback of HIV treatment is the development of viral strains that are resistant to the existing drugs and drug toxicity. 3 As a result, there is an on-going effort in the search for new compounds that are active against HIV. One of the sources for promising new HIV compounds is Chinese herbs, which are known to have anti-viral activity. Prunella vulgaris, Prunella laciniata and Prunella orientalis are representative species of the Prunella (Lamiaceae) genus which have been used in the treatment of the common cold, diarrhea, rheumatoid arthritis and cardiac arrhythmia. 4 The polar fraction of Prunella vulgaris also displays specific activity against the herpes simplex virus type 1 and 2. 5 Due to the wide variety of biological activity that Prunella vulgaris exhibits it was of particular interest and soxhlet ethanol extracts were tested for activity against HIV.
In addition to anti-viral activity, Prunella vulgaris extracts exhibit antihypersensitive, anti-hyperglycemic, anti-allergic, anti-inflammatory and cytotoxic activities. 6 A 10 kDa sulfated polysaccharide obtained from aqueous extracts of Prunella vulgaris has already been shown to inhibit HIV-1 replication with low cytotoxicity. 2 The two main ways in which Prunella vulgaris may be extracted are either under aqueous conditions or using alcohols, such as methanol or ethanol.
Extraction and Isolation
The first soxhlet extraction of Prunella vulgaris was done on the dried aerial part, which included the stems, leaves and flowers using EtOH (absolute 200 proof) for about 36
hours. The extract was concentrated under reduced pressure and stored at 0°C. The crude extract tested positive for anti-HIV activity and anti-inflammatory activity. The next step was to isolate different fractions and this was achieved by preparative TLC using CH2CI2. One preparative plate was developed and 8 fractions were isolated from the preparative plate.
There were four regions on the preparative TLC and each of these regions was divided into two regions, where the lower fractions were labeled Al, Bl, CI and Dl, and the upper fractions were labeled A2, B2, C2 and D2. These fractions were again tested for anti-HIV activity and anti-inflammatory activity.
Anti-HIV Activity found in Prunella vulgaris
Ethanol soxhlet extractions of dried Prunella vulgaris leaf and shoot material were tested for the ability to inhibit HIV replication. Non-cytotoxic concentrations of the extracts were effective at blocking HIV replication. The extract was fractionated into eight fractions, labeled 1 to 8, where fraction 1 corresponded to Al, fraction 2 to A2 through to fraction 8, which corresponded to D2. These fractions were tested against HIV and found to have some anti-viral activity across all fractions with two non-adjacent fractions, fraction 5 and 8, having the strongest anti-HIV activity with little associated cytotoxicity. This surprising result suggested that there are multiple components with anti-HIV activity present in Prunella vulgaris extracts. The data collected from this initial analysis is shown in Figure 1 .
The data collected on HIV replication and cytotoxicity are both represented in Figure 1 . With regards to the HIV data the best results are obtained from a reduction in the HIV replication.
In the cytotoxcity study the data shows that no cell death is occurring because the % control levels are above or relatively close to 100 %. These studies still are on-going. 
Anti-inflammatory Activity of Prunella vulgaris
The anti-inflammatory activity of Prunella vulgaris was investigated in cells with and without lipopolysaccharide (LPS) or endotoxin, which induces an inflammatory response.
LPS is commercially available from Sigma Aldrich. The level of reduction was always compared to the control which in this case corresponded to the control for the media and DSMO. Media was what made the cells grow. Mouse macrophage cells were used and were grown in a culture that is commercially available. These were treated with the Prunella vulgaris crude extract ( Figure 2 ) and after eight hours the prostaglandin E2 (PGE2) levels were observed. LPS was used to induce PGE2 production and the idea was to look for a reduction in the production of PGE2. There was a media control and a solvent control,
represented by the first two sets of data in Figure 2 . All three dose responses at concentrations of 136, 68 and 34 micrograms per milliliter were significant, even though at the lower concentrations of extract, there was less of an anti-inflammatory response. For the purpose of this experiment, the level of significance was determined by a p-value of < 0.05.
An asterisk was placed above any set of data that showed significance. A similar experiment was done on the fractions obtained from the preparative TLC of the crude extract. In addition to the other controls, there was a positive control represented by the last data set (labeled Quercetin), which ensured that the assay was working properly.
Quercetin is a flavanoid that is known to exhibit anti-inflammatory activity. The fraction which showed the most significant anti-inflammatory response in Figure 3 was fraction B2
obtained from the first extraction of Prunella vulgaris.
• even though the mechanism of immune activity has not yet been determined. 4 The active components in the Prunella extracts and which pathways they affect in the immune response have yet to be determined. 
Experimental Section
Unless otherwise noted, materials were obtained from commercial suppliers and used without purification. Ethanol soxhlet extraction was done on both the aerial part and root of Prunella vulgaris over 36 hours. All crude extracts are stored at 0 °C. Preparative TLC was carried out on Analtech silica gel plate (1000 microns) with UV 254 nm. The developing solvent used was CH2CI2. The fractions isolated were washed from the preparative TLC plate silica gel using 1:1 EtOAc and CH2CI2 
